Literature DB >> 25681095

Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among long-term opioid users in medicaid.

Zhuo Yang1, Barth Wilsey2, Michele Bohm3, Meghan Weyrich4, Kakoli Roy5, Dominique Ritley4, Christopher Jones6, Joy Melnikow4.   

Abstract

UNLABELLED: Use of multiple pharmacies concurrently (pharmacy shopping) and overlapping prescriptions may be indicators of potential misuse or abuse of prescription opioid medications. To evaluate strategies for identifying patients at high risk, we first compared different definitions of pharmacy shopping and then added the indicator of overlapping opioid prescriptions. We identified a cohort of 90,010 Medicaid enrollees who used ≥ 3 opioid prescriptions for ≥ 90 days during 2008 to 2010 from a multistate Medicaid claims database. We compared the diagnostic odds ratios for opioid overdose events of 9 pharmacy shopping definitions. Within a 90-day interval, a threshold of 4 pharmacies had the highest diagnostic odds ratio and was used to define pharmacy shopping. The overdose rate was higher in the subgroup with overlapping prescriptions (18.5 per 1,000 person-years [PYs]) than in the subgroup with pharmacy shopping as the sole indicator (10.7 per 1,000 PYs). Among the subgroup with both conditions, the overdose rate was 26.3 per 1,000 PYs, compared with 4.3 per 1,000 PYs for those with neither condition. Overlapping opioid prescriptions and pharmacy shopping measures had adjusted hazard ratios of 3.0 and 1.8, respectively, for opioid overdose. Using these measures will improve accurate identification of patients at highest risk of opioid overdose, the first step in implementing targeted prevention policies. PERSPECTIVE: Long-term prescription opioid use may lead to adverse events, including overdose. Both pharmacy shopping and overlapping opioid prescriptions are associated with adverse outcomes. This study demonstrates that using both indicators will better identify those at high risk of overdose. Published by Elsevier Inc.

Entities:  

Keywords:  Prescription opioids; overdose risk factors; overlapping prescriptions; pharmacy shopping

Mesh:

Substances:

Year:  2015        PMID: 25681095     DOI: 10.1016/j.jpain.2015.01.475

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  47 in total

1.  Prescribing Associated with High-Risk Opioid Exposures Among Non-cancer Chronic Users of Opioid Analgesics: a Social Network Analysis.

Authors:  Keiki Hinami; Michael J Ray; Kruti Doshi; Maria Torres; Steven Aks; John J Shannon; William E Trick
Journal:  J Gen Intern Med       Date:  2019-08-16       Impact factor: 5.128

2.  High-Risk Prescribing to Medicaid Enrollees Receiving Opioid Analgesics: Individual- and County-Level Factors.

Authors:  Sara E Heins; Mark J Sorbero; Christopher M Jones; Andrew W Dick; Bradley D Stein
Journal:  Subst Use Misuse       Date:  2018-01-05       Impact factor: 2.164

3.  Dental opioid prescribing and multiple opioid prescriptions among dental patients: Administrative data from the South Carolina prescription drug monitoring program.

Authors:  Jenna L McCauley; J Madison Hyer; V Ramesh Ramakrishnan; Renata Leite; Cathy L Melvin; Roger B Fillingim; Christie Frick; Kathleen T Brady
Journal:  J Am Dent Assoc       Date:  2016-04-05       Impact factor: 3.634

4.  Care Coordination for Patients on Chronic Opioid Therapy Following Surgery: A Cohort Study.

Authors:  Pooja Lagisetty; Amy Bohnert; Jenna Goesling; Hsou Mei Hu; Breanna Travis; Kiran Lagisetty; Chad M Brummett; Michael J Englesbe; Jennifer Waljee
Journal:  Ann Surg       Date:  2019-03-01       Impact factor: 12.969

5.  Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City.

Authors:  Marcus A Bachhuber; Ellenie Tuazon; Michelle L Nolan; Hillary V Kunins; Denise Paone
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-03-28       Impact factor: 2.890

6.  Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids.

Authors:  Mohamed Noureldin; Peter D R Higgins; Shail M Govani; Shirley Cohen-Mekelburg; Brooke C Kenney; Ryan W Stidham; Jennifer F Waljee; Akbar K Waljee
Journal:  Aliment Pharmacol Ther       Date:  2018-11-14       Impact factor: 8.171

7.  Does Prescription Opioid Shopping Increase Overdose Rates in Medicaid Beneficiaries?

Authors:  Benjamin C Sun; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell
Journal:  Ann Emerg Med       Date:  2017-11-24       Impact factor: 5.721

8.  Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011-2015.

Authors:  Adam J Rose; Dana Bernson; Kenneth Kwan Ho Chui; Thomas Land; Alexander Y Walley; Marc R LaRochelle; Bradley D Stein; Thomas J Stopka
Journal:  J Gen Intern Med       Date:  2018-06-14       Impact factor: 5.128

9.  Predicting Opioid Use, Increased Health Care Utilization and High Costs for Musculoskeletal Pain: What Factors Mediate Pain Intensity and Disability?

Authors:  Trevor A Lentz; Daniel I Rhon; Steven Z George
Journal:  J Pain       Date:  2019-06-13       Impact factor: 5.820

10.  Machine learning for phenotyping opioid overdose events.

Authors:  Jonathan Badger; Eric LaRose; John Mayer; Fereshteh Bashiri; David Page; Peggy Peissig
Journal:  J Biomed Inform       Date:  2019-04-25       Impact factor: 6.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.